Clinical Trial: A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition:
Chronic Kidney Failure
End-Stage Renal Disease
Renal Impairment
Study Type: INTERVENTIONAL
Official Title: An Open-Label, Single-Dose Clinical Study to Evaluate the Pharmacokinetics of MK-2828 in Participants With Renal Impairment
Brief Summary:
The goal of this trial is to measure what happens to 1 or 2 doses of MK-2828 in a person's body over time (pharmacokinetic or PK trial). Researchers want to learn if the PK of people with certain types of kidney disease is similar to the PK of healthy people.
Read more